{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:59:58Z","timestamp":1776085198950,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017025","name":"European Geriatric Medicine Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Healthy Longevity"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/s2666-7568(23)00208-8","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T02:34:59Z","timestamp":1700015699000},"page":"e724-e729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Inclusion of functional measures and frailty in the development and evaluation of medicines for older adults"],"prefix":"10.1016","volume":"4","author":[{"given":"Michael","family":"Denkinger","sequence":"first","affiliation":[]},{"given":"Wilma","family":"Knol","sequence":"additional","affiliation":[]},{"given":"Antonio","family":"Cherubini","sequence":"additional","affiliation":[]},{"given":"Anita","family":"Simonds","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Lionis","sequence":"additional","affiliation":[]},{"given":"Denis","family":"Lacombe","sequence":"additional","affiliation":[]},{"given":"Elena","family":"Petelos","sequence":"additional","affiliation":[]},{"given":"Mary","family":"McCarthy","sequence":"additional","affiliation":[]},{"given":"Patrick","family":"Ouvrard","sequence":"additional","affiliation":[]},{"given":"Philip","family":"Van Kerrebroeck","sequence":"additional","affiliation":[]},{"given":"Piotr","family":"Szyma\u0144ski","sequence":"additional","affiliation":[]},{"given":"Amelia","family":"Cupelli","sequence":"additional","affiliation":[]},{"given":"Andrea","family":"Laslop","sequence":"additional","affiliation":[]},{"given":"Armin","family":"Koch","sequence":"additional","affiliation":[]},{"given":"Bruno","family":"Sepodes","sequence":"additional","affiliation":[]},{"given":"Carla","family":"Torre","sequence":"additional","affiliation":[]},{"given":"Elina","family":"R\u00f6nnemaa","sequence":"additional","affiliation":[]},{"given":"Ewa","family":"Ba\u0142kowiec-Iskra","sequence":"additional","affiliation":[]},{"given":"Maria Teresa","family":"Herdeiro","sequence":"additional","affiliation":[]},{"given":"M\u00e1rio Miguel","family":"Rosa","sequence":"additional","affiliation":[]},{"given":"Martine","family":"Trauffler","sequence":"additional","affiliation":[]},{"given":"Nikica","family":"Miro\u0161evi\u0107 Skvrce","sequence":"additional","affiliation":[]},{"given":"Sabine","family":"Mayrhofer","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Berntgen","sequence":"additional","affiliation":[]},{"given":"Ivana","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Francesca","family":"Cerreta","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S2666-7568(23)00208-8_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fmed.2019.00133","article-title":"Frailty and intrinsic capacity: two distinct but related constructs","volume":"6","author":"Belloni","year":"2019","journal-title":"Front Med"},{"key":"10.1016\/S2666-7568(23)00208-8_bib2","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/ageing\/afl041","article-title":"Validity and reliability of the Edmonton Frail Scale","volume":"35","author":"Rolfson","year":"2006","journal-title":"Age Ageing"},{"key":"10.1016\/S2666-7568(23)00208-8_bib3","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2666-7568(23)00208-8_bib4","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/gerona\/62.7.722","article-title":"Frailty in relation to the accumulation of deficits","volume":"62","author":"Rockwood","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2666-7568(23)00208-8_bib5","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(19)31786-6","article-title":"Frailty: implications for clinical practice and public health","volume":"394","author":"Hoogendijk","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2666-7568(23)00208-8_bib6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1186\/s12877-020-01935-8","article-title":"The impact of interventions on management of frailty in hospitalized frail older adults: a systematic review and meta-analysis","volume":"20","author":"Rezaei-Shahsavarloo","year":"2020","journal-title":"BMC Geriatr"},{"key":"10.1016\/S2666-7568(23)00208-8_bib7","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/jamasurg.2014.296","article-title":"Superiority of frailty over age in predicting outcomes among geriatric trauma patients: a prospective analysis","volume":"149","author":"Joseph","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/S2666-7568(23)00208-8_bib8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00391-016-1128-8","article-title":"Significance of frailty for predicting adverse clinical outcomes in different patient groups with specific medical conditions","volume":"49","author":"Ritt","year":"2016","journal-title":"Z Gerontol Geriatr"},{"key":"10.1016\/S2666-7568(23)00208-8_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11357-017-9960-3","article-title":"The frailty index outperforms DNA methylation age and its derivatives as an indicator of biological age","volume":"39","author":"Kim","year":"2017","journal-title":"GeroScience"},{"key":"10.1016\/S2666-7568(23)00208-8_bib10","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1093\/gerona\/glaa291","article-title":"Beyond chronological age: frailty and multimorbidity predict in-hospital mortality in patients with coronavirus disease 2019","volume":"76","author":"Marengoni","year":"2021","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2666-7568(23)00208-8_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.21037\/atm-22-274","article-title":"Predictive value of frailty in the mortality of hospitalized patients with COVID-19: a systematic review and meta-analysis","volume":"10","author":"Zou","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/S2666-7568(23)00208-8_bib12","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/j.1532-5415.2010.03032.x","article-title":"Fighting against age discrimination in clinical trials","volume":"58","author":"Cherubini","year":"2010","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2666-7568(23)00208-8_bib15","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1001\/jama.2018.12368","article-title":"Inclusion across the lifespan: NIH policy for clinical research","volume":"320","author":"Bernard","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/S2666-7568(23)00208-8_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/oncolo\/oyad072","article-title":"Missed opportunities in geriatric oncology research","volume":"28","author":"Lichtman","year":"2023","journal-title":"Oncologist"},{"key":"10.1016\/S2666-7568(23)00208-8_bib17","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jamainternmed.2020.2750","article-title":"Representation of older adults in cardiovascular disease trials since the inclusion across the lifespan policy","volume":"180","author":"Nanna","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"suppl 15","key":"10.1016\/S2666-7568(23)00208-8_bib18","article-title":"FDA analysis of enrollment of older adults in clinical trials for cancer drug registration: a 10-year experience by the US Food and Drug Administration","volume":"35","author":"Singh","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2666-7568(23)00208-8_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101455","article-title":"Underrepresentation of older adults in clinical trials on COVID-19 vaccines: a systematic review","volume":"71","author":"Veronese","year":"2021","journal-title":"Ageing Res Rev"},{"key":"10.1016\/S2666-7568(23)00208-8_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.36149","article-title":"Participation of older adults in clinical trials for new drug applications and biologics license applications from 2010 through 2019","volume":"5","author":"Lau","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2666-7568(23)00208-8_bib21","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/jamaoncol.2019.2055","article-title":"Factors associated with age disparities among cancer clinical trial participants","volume":"5","author":"Ludmir","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/S2666-7568(23)00208-8_bib22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41408-022-00779-2","article-title":"The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: a systematic review","volume":"13","author":"Mian","year":"2023","journal-title":"Blood Cancer J"},{"key":"10.1016\/S2666-7568(23)00208-8_bib23","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/S2666-7568(21)00280-4","article-title":"Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women","volume":"3","author":"Carleton","year":"2022","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/S2666-7568(23)00208-8_bib24","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.23.00933","article-title":"Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update","volume":"41","author":"Dale","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2666-7568(23)00208-8_bib25","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1200\/OP.23.00263","article-title":"Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline questions and answers","volume":"19","author":"Williams","year":"2023","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/S2666-7568(23)00208-8_bib26","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/S2666-7568(23)00088-0","article-title":"Representative enrolment of older adults in clinical trials: the time is now","volume":"4","author":"Schwartz","year":"2023","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/S2666-7568(23)00208-8_bib28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4235\/agmr.20.0002","article-title":"Measuring frailty in health care databases for clinical care and research","volume":"24","author":"Kim","year":"2020","journal-title":"Ann Geriatr Med Res"},{"key":"10.1016\/S2666-7568(23)00208-8_bib30","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1001\/jama.2022.6421","article-title":"Ethical considerations for the inclusion of patient-reported outcomes in clinical research: the PRO ethics guidelines","volume":"327","author":"Cruz Rivera","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/S2666-7568(23)00208-8_bib31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/cpt.2452","article-title":"Roadmap to 2030 for drug evaluation in older adults","volume":"112","author":"Liu","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/S2666-7568(23)00208-8_bib33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/cpt.2151","article-title":"Evaluating patients with impaired renal function during drug development: highlights from the 2019 US FDA Pharmaceutical Science and Clinical Pharmacology Advisory Committee meeting","volume":"110","author":"Sahre","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/S2666-7568(23)00208-8_bib34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cger.2017.09.004","article-title":"Frailty screening and interventions: considerations for clinical practice","volume":"34","author":"Walston","year":"2018","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/S2666-7568(23)00208-8_bib35","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/jamainternmed.2022.1657","article-title":"Time to clinical benefit of intensive blood pressure lowering in patients 60 years and older with hypertension: a secondary analysis of randomized clinical trials","volume":"182","author":"Chen","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2666-7568(23)00208-8_bib36","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1001\/jamacardio.2022.3750","article-title":"Time to clinical benefit of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction: a prespecified secondary analysis of the DELIVER randomized clinical trial","volume":"7","author":"Vaduganathan","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/S2666-7568(23)00208-8_bib37","first-page":"78","article-title":"Older adult participation in cancer clinical trials: a systematic review of barriers and interventions","volume":"71","author":"Sedrak","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/S2666-7568(23)00208-8_bib38","first-page":"272","article-title":"Clinical trial outcomes: what matters to patients","volume":"7","author":"Martinez","year":"2019","journal-title":"J Am Coll Cardiol HF"},{"key":"10.1016\/S2666-7568(23)00208-8_bib39","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s12603-019-1273-z","article-title":"Physical frailty: ICFSR international clinical practice guidelines for identification and management","volume":"23","author":"Dent","year":"2019","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/S2666-7568(23)00208-8_bib40","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/eurjpc\/zwaa167","volume":"29","author":"Richter","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/S2666-7568(23)00208-8_bib41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12916-020-01752-1","article-title":"Identifying frailty in trials: an analysis of individual participant data from trials of novel pharmacological interventions","volume":"18","author":"Hanlon","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/S2666-7568(23)00208-8_bib42","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/jgs.16917","article-title":"Recombinant zoster vaccine is efficacious and safe in frail individuals","volume":"69","author":"Curran","year":"2021","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2666-7568(23)00208-8_bib43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/ageing\/aft160","article-title":"The frailty phenotype and the frailty index: different instruments for different purposes","volume":"43","author":"Cesari","year":"2014","journal-title":"Age Ageing"},{"key":"10.1016\/S2666-7568(23)00208-8_bib44","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s40262-019-00822-9","article-title":"Physiologically based pharmacokinetic modelling to identify pharmacokinetic parameters driving drug exposure changes in the elderly","volume":"59","author":"Stader","year":"2020","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/S2666-7568(23)00208-8_bib45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10928-022-09805-z","article-title":"Two heads are better than one: current landscape of integrating QSP and machine learning","volume":"49","author":"Zhang","year":"2022","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/S2666-7568(23)00208-8_bib46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2016.12.023","article-title":"Series: pragmatic trials and real world evidence: paper 1. Introduction","volume":"88","author":"Zuidgeest","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S2666-7568(23)00208-8_bib47","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1200\/JCO.21.00165","article-title":"Decision making in older adults with cancer","volume":"39","author":"DuMontier","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2666-7568(23)00208-8_bib48","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/gerona\/63.2.160","article-title":"Functional outcomes for clinical trials in frail older persons: time to be moving","volume":"63","year":"2008","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2666-7568(23)00208-8_bib49","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejca.2018.07.137","article-title":"Multidisciplinary development of the geriatric core dataset for clinical research in older patients with cancer: a French initiative with international survey","volume":"103","author":"Paillaud","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/S2666-7568(23)00208-8_bib50","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12877-022-02993-w","article-title":"An international Delphi consensus process to determine a common data element and core outcome set for frailty: FOCUS (The Frailty Outcomes Consensus Project)","volume":"22","author":"Prorok","year":"2022","journal-title":"BMC Geriatr"}],"container-title":["The Lancet Healthy Longevity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666756823002088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666756823002088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T04:31:56Z","timestamp":1763008316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666756823002088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2666756823002088"],"URL":"https:\/\/doi.org\/10.1016\/s2666-7568(23)00208-8","relation":{},"ISSN":["2666-7568"],"issn-type":[{"value":"2666-7568","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inclusion of functional measures and frailty in the development and evaluation of medicines for older adults","name":"articletitle","label":"Article Title"},{"value":"The Lancet Healthy Longevity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2666-7568(23)00208-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}